0001567619-21-004470.txt : 20210218
0001567619-21-004470.hdr.sgml : 20210218
20210218184308
ACCESSION NUMBER: 0001567619-21-004470
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210216
FILED AS OF DATE: 20210218
DATE AS OF CHANGE: 20210218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LAWLIS V BRYAN
CENTRAL INDEX KEY: 0001247681
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26727
FILM NUMBER: 21651193
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC
CENTRAL INDEX KEY: 0001048477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680397820
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 4155066700
MAIL ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
4
1
doc1.xml
FORM 4
X0306
4
2021-02-16
0
0001048477
BIOMARIN PHARMACEUTICAL INC
BMRN
0001247681
LAWLIS V BRYAN
C/O BIOMARIN PHARMACEUTICAL INC.
105 DIGITAL DRIVE
NOVATO
CA
94949
1
0
0
0
Common Stock
2021-02-16
4
M
0
7500
26.49
A
26350
D
Common Stock
2021-02-16
4
S
0
7500
87.41
D
18850
D
Stock Option (Right to buy Common Stock)
26.49
2021-02-16
4
M
0
7500
0
D
2011-11-12
2021-05-11
Common Stock
7500
7500
D
Trade made pursuant to a 10b5-1 plan executed on January 16, 2020, as amended on August 21, 2020.
Reflects the number of options outstanding after the transactions from this specific stock option grant.
/s/ Eric Fleekop, Attorney-in-Fact
2021-02-18